Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
36 participants
INTERVENTIONAL
2018-05-10
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Application Research on Endoscopic Pseudocapsule-Based Resection for Pituitary Adenomas
NCT05466357
The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor
NCT01377701
A Twenty-years' Experience in Pituitary Disease.
NCT06973824
Long-Term Outcomes of Hypopituitarism Following Gamma Knife Radiosurgery for Pituitary Adenomas
NCT07015645
Prognosis of Atypical Pituitary Adenomas
NCT00473369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
microsurgical technique
Microsurgical resection
Transsphenoidal microsurgical resection of pituitary adenoma
endoscopic technique
Endoscopic resection
Transsphenoidal endoscopic resection of pituitary adenoma
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopic resection
Transsphenoidal endoscopic resection of pituitary adenoma
Microsurgical resection
Transsphenoidal microsurgical resection of pituitary adenoma
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent
Exclusion Criteria
* No follow-up possible
* Emergency surgery without informed consent or without intraoperative MRI
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ulm
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrej Pala
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrej Pala, MD
Role: PRINCIPAL_INVESTIGATOR
University Ulm, Department of Neurosurgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurosurgery
Günzburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pala A, Grubel N, Mayer B, Becker R, Sommer F, Schmitz B, Etzrodt-Walter G, Wirtz CR, Hlavac M. Endocrine Outcome and Quality of Life After Transsphenoidal Resection of Pituitary Adenoma-A Prospective Randomized Single-Blinded Study Comparing Endoscopic Versus Microscopic Resection. Neurol Int. 2025 Jan 10;17(1):5. doi: 10.3390/neurolint17010005.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EndOSPA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.